UNSPSC 51282521: Cefadroxil monohydrate

This classification denotes a cephalosporin antibiotic with the molecular formula C16H17N3O5S.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 280111G160, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-, (6r-(6-alpha,7-beta(r*)))- but more generally known as cefadroxil, which bears US NIH Compound Identifier 2610. Cefadroxil most often comes in base, hydrate, and hemihydrate forms.

UNSPSC 51282521 Cefadroxil monohydrate is a Commodity code for a specific antibiotic pharmaceutical product, yet the recent state and local opportunities tagged under it do not actually solicit cefadroxil monohydrate. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through MMCAP Infuse to Chartwell Rx LLC for doxycycline hyclate and ciprofloxacin hydrochloride tablets, and Seminole County, Florida issued an IFB for naloxone and drug deactivation systems. These solicitations reflect state and local health and public-safety procurement of specific pharmaceutical products and medical supplies, typically through direct awards from state health departments or county procurement offices using cooperative purchasing vehicles and competitive bidding processes.

Activity under this code appears concentrated in Florida and Illinois based on the recent record. The Illinois Department of Public Health contract, awarded August 28, 2026, supplies doxycycline hyclate 100mg and ciprofloxacin hydrochloride 500mg in 20-count packages to support the state's pharmaceutical warehouse on a 12-month initial term with renewal options through year 3, totaling $2,999,999.11 over the contract life; Seminole County's IFB, posted June 30, 2026 with response due July 26, 2023, seeks annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries and a two-year initial term plus one-year renewal option. The mismatch between the code's nominal scope and the actual pharmaceutical products being solicited suggests limited direct cefadroxil monohydrate activity in recent state and local procurement.